topics / oncology

Tagged oncology.

10/10 · Established Exemestane (Aromasin) Exemestane is an oral, steroidal third-generation aromatase inhibitor — an FDA-approved breast-cancer drug, not a peptide. Bodybuilders use it off-label to suppress estrogen, an unapproved and unstudied practice that is banned in sport (WADA S4) and can be genuinely harmful when estrogen is crashed.
10/10 · Established Letrozole (Femara) Letrozole is an oral, nonsteroidal third-generation aromatase inhibitor — an FDA-approved breast-cancer and (off-label) fertility drug, not a peptide. Bodybuilders use it off-label to suppress estrogen, an unapproved and unstudied practice that is banned in sport (WADA S4) and can be genuinely harmful when estrogen is crashed.
10/10 · Established Tamoxifen (Nolvadex) Tamoxifen is a selective estrogen receptor modulator (SERM) — an FDA-approved breast-cancer drug with one of the strongest evidence bases in oncology, not a peptide. Anabolic-steroid users take it off-label to blunt gynecomastia and attempt testosterone 'restart,' an unstudied practice that is banned in sport (WADA S4.2) and not without real risk.